Tzu-Hsiu Chen

发表

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

Thomas LaFramboise, Levi A Garraway, Kwok-Kin Wong, 2006, Nature Medicine.

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

Wendy Winckler, Gad Getz, Steven A Carr, 2012, Proceedings of the National Academy of Sciences.

Missense mutations of the BRAF gene in human lung adenocarcinoma.

M. Meyerson, W. Richards, D. Sugarbaker, 2002, Cancer research.

Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants

William C Hahn, Matthew Meyerson, William R Sellers, 2005, PLoS medicine.

High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines

David C Christiani, Cheng Li, Luc Girard, 2004, Oncogene.

Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway.

Tsung-Ying Yang, Kun-Chieh Chen, Chun-Chi Wu, 2013, Life sciences.

Abstract 1: Oncogenic extracellular domain mutations of ERBB2 in cancer

Jacob D. Jaffe, G. Getz, M. Meyerson, 2012 .

Interleukin-6 upregulates paraoxonase 1 gene expression via an AKT/NF-κB-dependent pathway.

S. Hsu, Tzu-Hsiu Chen, Chi-Chih Cheng, 2013, Biochemical and biophysical research communications.

The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells

Tsung-Ying Yang, S. Hsu, Chun-Chi Wu, 2015, PloS one.

TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis.

Tzu-Hsiu Chen, Sien‐Sing Yang, Ching-Shan Huang, 2000, World journal of gastroenterology.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays.

Luc Girard, Matthew Meyerson, Xiaojun Zhao, 2004, Cancer research.

Arrays the Cancer Genome Using Single Nucleotide Polymorphism An Integrated View of Copy Number and Allelic Alterations in Updated

M. Meyerson, W. Sellers, K. Chin, 2004 .

Destruxin B Isolated from Entomopathogenic Fungus Metarhizium anisopliae Induces Apoptosis via a Bcl-2 Family-Dependent Mitochondrial Pathway in Human Nonsmall Cell Lung Cancer Cells

Bing-Lan Liu, Y. Tzeng, S. Hsu, 2013, Evidence-based complementary and alternative medicine : eCAM.

Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation.

Martin Peifer, Daniel Rauh, Lars Ruddigkeit, 2010, Cancer research.

Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors

M. Meyerson, Jeffrey C. Lee, H. Ji, 2007, Cancer biology & therapy.

RET fusions observed in lung and colorectal cancers are sensitive to ponatinib

J. Pritchard, H. Edgren, Tzu-Hsiu Chen, 2018, Oncotarget.

Drug-sensitive FGFR2 mutations in endometrial carcinoma

Kristian Cibulskis, Wendy Winckler, Michael C Zody, 2008, Proceedings of the National Academy of Sciences.

Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways

Y. Tzeng, S. Hsu, Tzu-Hsiu Chen, 2017, Evidence-based complementary and alternative medicine : eCAM.

Comprehensive Analysis Of The In Vitro Potency Of Ponatinib, and All Other Approved BCR-ABL Tyrosine Kinase Inhibitors (TKIs), Against a Panel Of Single and Compound BCR-ABL Mutants

T. Clackson, Tzu-Hsiu Chen, V. Rivera, 2013 .

Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors.

J. Rothberg, J. Simons, M. Meyerson, 2005, Cold Spring Harbor symposia on quantitative biology.

Abstract 2726: RET fusions identified in colorectal cancer PDX models are sensitive to the potent RET inhibitor ponatinib

T. Clackson, Tzu-Hsiu Chen, V. Rivera, 2014 .